2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Steffel, Jan; Collins, Rónán; Antz, Matthias; Cornu, Pieter; Desteghe, Lien; Georg Hæusler, Karl; Oldgren, Jonas; Reinecke, Holger; Roldan-Schilling, Vanessa; Rowell, Nigel; Sinnaeve, Peter; Vanassche, Thomas; Potpara, Tatjana; John Camm, A.; Heidbüchel, Hein; reviewers, External; Y.H. Lip, Gregory; Deneke, Thomas; Dagres, Nikolaos; Boriani, Giuseppe; Chao, Tze-Fan; Choi, Eue‐Keun; True Hills, Mellanie; S Santos, Itamar; A. Lane, Deirdre; Atar, Dan; Joung, Boyoung; Maria Cole, Oana; Field, Mark

doi:10.1093/europace/euab065

Public

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Published in EP Europace • Mar 4, 2021

Authors:

Jan Steffel

Rónán Collins

Matthias Antz

Abstract

CV Cardiovascular CYP Cytochrome P (CYP) Unfractionated heparin ULN Upper limit of normal VENTURE-AF Active-controlled multi-center study with blind-adjudication designed to evaluate the safety of uninterrupted Rivaroxaban and uninterrupted vitamin K antagonists in subjects undergoing catheter ablat...

Subject

Medicine

Vitamin K antagonist

Atrial fibrillation

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!